Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Why This Psychedelics Company is Focused on Weight Management

Psychedelics are transforming so many aspects of our everyday lives — from treating mental health conditions to weight management and obesity. Companies like NeonMind Biosciences ( CSE:NEON , OTCQB:NMDBD , Forum ) are at the forefront of this innovation ...
Jocelyn Aspa | May 4, 2022 |

Receive 7% dividends from America's most profitable stock

Makers of cigarettes and the U.S. government must play a bizarre game... and not one American in 100,000 understands it. Everyone knows cigarettes are "evil." On Friday, the state of Kansas will ban smoking in indoor public places. And in San Francisco, they're cl...
Tom Dyson | October 28, 2012 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

Buzz on the Bullboards: Celebrating Success in Difficult Times with an Eye to a Profitable 2021.

As we continue the fight against the COVID-19 pandemic, the recent global rollout of effective vaccines to win the battle against the coronavirus gives us pause to give hope for a better 2021 and reflect on some of the amazing accomplishments both individuals and companie...
Dave Jackson | December 23, 2020 |

BAT, Barrick Gold, Osino Resources: Supposed political risks, a burden, and an opportunity

Businesses, like citizens, operate within the regulatory framework. In this way, the state guarantees peaceful coexistence. But what if the legal framework changes? It is easy for individuals to adapt to new circumstances. It can be more challenging for companies - for example...
Nico Popp | October 1, 2020 |

Shaping the Future of Medicine by Delivering Regenerative Medicines

(Click image to play video) Envision a chest pain that feels like the most severe form of heartburn you ever experienced before. This is one of the main symptoms of ischemia – a disease which millions of people around the globe live with every day. Treati...
Dave Jackson | December 8, 2020 |

Shaping the Future of Regenerative Medicine Today

(Click image to play video) Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF , Forum ) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The Company’...
Dave Jackson | February 10, 2021 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

Geophysical work begins at Finland palladium play

Palladium has found another gear as it races past $2,200 an ounce, leaving its sister platinum-group metal platinum, and even gold, eating its dust. On Tuesday palladium (Pd) hit a record $2,191 an ounce, building on nine straight sessions of gains, but even that wasn&Clo...
Richard (Rick) Mills | January 23, 2020 |
1 2 3